Flash Player
Flash Player

You need a Flash Player in order to view some content. You are about to be directed to Macromedia Flash Player Download Center.

Click the CONTINUE button below to go to the Macromedia Flash Player Download Center, or the CANCEL button to return to the previous page.

NOTE: After installation is complete, please restart your browser.

Cancel
Continue
Flash Player
For U.S. Residents Only
Save up to $100 on Apidra® Prescriptions Apidra® SoloSTAR® Pen

Frequently Asked Questions

Questions you may have about the Apidra® SoloSTAR® pen

Do I use a new pen every time I inject?
No. Each APIDRA® SoloSTAR® pen contains 300 units of insulin and is good for 28 days once it is in use. That means 28 days after you use your pen for the first time, you will need to throw the pen away—even if there is still medicine inside. You should never use your APIDRA® SoloSTAR® pen past its expiration date.

Is it OK to use the same needle more than once?
No. Always attach a new sterile needle before each use. Using the same needle may cause contamination, air bubbles, and other complications such as needle blocks.

Do I need to keep my APIDRA® SoloSTAR® pen refrigerated after it is opened or in use?
No. Do NOT refrigerate your pen once it is in use. Once you use your pen for the first time, it will last up to 28 days when kept at room temperature (below 77º F).

I thought insulin was supposed to be kept in the refrigerator.
You are right. Unopened insulin must be stored in the refrigerator at a temperature between 36°F-46°F (2°C-8°C). Before you use the pens, keep them in the outer package and in the refrigerator.

What do I do if there is not enough insulin left in the pen for my injection?
The APIDRA® SoloSTAR® pen prevents you from dialing past the number of units left in the pen. If there isn’t enough insulin for your full dose, you can complete your dose by calculating how much more you will need from a new pen. For example: If you normally use 41 units and there are only 12 units left in your pen, you will need 29 units from the new pen. Inject the remaining insulin from the first pen, and then inject the appropriate amount with the new pen to complete your dose. Or, you can just use a new pen for your full dose.

How do I take care of the APIDRA® SoloSTAR® pen?
It’s important to protect your pen from dust and dirt, so you can clean the outside of your SoloSTAR® pen by wiping it with a damp cloth. Do not run it under water or use any soap or solvents.

How do I get the APIDRA® SoloSTAR® pen?
The APIDRA® SoloSTAR® pen is available by prescription only. Ask your doctor if the APIDRA® SoloSTAR® pen is right for you.

Important Safety Information for Apidra®

Do not use Apidra® during a low blood sugar reaction (hypoglycemia) or if you are allergic to any of the ingredients in Apidra®.

You must test your blood sugar levels while using insulin, such as Apidra®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision. Apidra® must only be used if the solution is clear and colorless with no particles visible. Do not share needles, insulin pens or syringes with others.

Apidra®, when given by injection under the skin, should not be mixed with insulins other than NPH. Do not mix Apidra® with any insulin when used in the pump or for intravenous administration.

The most common side effect of insulin, including Apidra®, is low blood sugar (hypoglycemia), which may be serious. Some people may experience symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia can be dangerous and can cause harm to your heart or brain. It may cause unconsciousness, seizures, or death. Other possible side effects may include low blood potassium, injection site reactions, such as changes in fat tissue at the injection site, and allergic reactions, such as itching and rash. Less common, but potentially more serious or life-threatening, is generalized allergy to insulin, including anaphylactic reactions.

Tell your doctor about other medicines and supplements you are taking because they can change the way insulin works. Before starting Apidra®, tell your doctor about all your medical conditions including if you have liver or kidney problems, are pregnant or planning to become pregnant, or are breast-feeding or planning to breast-feed.

If the pump or infusion set does not work right, you may not receive the right amount of insulin. Hypoglycemia, hyperglycemia, or ketosis can happen. Problems should be identified and corrected as quickly as possible. Change the Apidra® in the pump reservoir every 48 hours.

Indications and Usage

Prescription Apidra® is for adults with type 2 diabetes or adults and children (4 years and older) with type 1 diabetes to improve blood sugar control. Apidra® is usually used with a longer-acting insulin. When used as a mealtime insulin, Apidra® should be given within 15 minutes before or within 20 minutes after starting a meal.

Apidra® may be infused subcutaneously by external insulin infusion pumps.

Apidra® SoloSTAR® is a disposable prefilled insulin pen.

Click here for additional important information for Apidra®.

Important Safety Information for Lantus® (insulin glargine [rDNA origin] injection)

Do not take Lantus® if you are allergic to insulin or any of the inactive ingredients in Lantus®.

You must test your blood sugar levels while using insulin, such as Lantus®. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.

Do NOT dilute or mix Lantus® with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus® must only be used if the solution is clear and colorless with no particles visible. Do not share needles, insulin pens or syringes with others.

The most common side effect of insulin, including Lantus®, is low blood sugar (hypoglycemia), which may be serious. Some people may experience symptoms such as shaking, sweating, fast heartbeat, and blurred vision. Severe hypoglycemia can be dangerous and can cause harm to your heart or brain. It may cause unconsciousness, seizures, or death. Other possible side effects may include injection site reactions, including changes in fat tissue at the injection site, and allergic reactions, including itching and rash. In rare cases, some allergic reactions may be life threatening.

Tell your doctor about other medicines and supplements you are taking because they can change the way insulin works. Before starting Lantus®, tell your doctor about all your medical conditions including if you have liver or kidney problems, are pregnant or planning to become pregnant, or are breast-feeding or planning to breast-feed.

Indications and Usage

Prescription Lantus® is a long-acting insulin used to treat adults with type 2 diabetes and adults and children (6 years and older) with type 1 diabetes for the control of high blood sugar. It should be taken once a day at the same time each day to lower blood glucose.

Do not use Lantus® to treat diabetic ketoacidosis.

Click here for additional important information for Lantus®.

Click here for information on Sharps Medical Waste Disposal.

Click here for information on drug anti-counterfeiting.

• Offer is not valid for patients participating in Medicare, Medicaid, or any other federal- or state funded benefit programs. Offer not valid in MA (except for cash-paying patients). Void where prohibited by law.

The health information contained herein is provided for general educational purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.